Bionano Genomics Inc. (NASDAQ:BNGO) stock has tumbled to a 52-week low, touching down at $4.9 as the company faces a challenging market environment. According to InvestingPro data, the stock's RSI ...

The company, founded by 25-year-old Kian Sadeghi, announced a $14 million Series A, bringing its total funding to about $32 million.

MIT chemists use generative AI to predict 3D genomic structures quickly, a process far faster than current methods.

A team of investigators from Dana-Farber Cancer Institute, The Broad Institute of MIT and Harvard, Google, and Columbia ...

Figuring out how your genes and environment increase your likelihood of developing asthma, heart disease, cancer, dementia ...

An international collaboration of scientists have made a groundbreaking discovery that could positively impact the ...

ATx has created groundbreaking drugs for dementia and Alzheimer’s. The Icelandic startup just raised €26mn to advance the ...

EST Cathie Wood’s ARK Investment buys 370K shares of 10x Genomics (TXG) todayInvest with Confidence: Follow TipRanks' Top Wall Street ...

A significant advancement in knowledge of the link between cognition and genetics has been made thanks to a study led by ...

Farmers have the chance to explore the fascinating world of genomics with the help of an expert panel of leading crop ...

Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (the "Company" or "Moss") is pleased to announce a non-brokered private placement of up to ...